In pharma today, everyone and no one owns the customer. ZS’s vision of the commercial model of the future focuses on addressing that problem. ZS principal Namita Powers talked with Kana Hutton, senior project director, pharma, global, at Reuters, about our vision for a new commercial model during Pharma USA 2024. This conversation is part of “Pharma Pulse,” a podcast by Reuters Events Pharma.
Watch to find out the three moves that companies can make towards creating behavior-changing, personalized customer engagement at scale, as well as the true meaning of “unbundling the rep“ and the role of AI in a new model.
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
